Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Tizona Therapeutics, Inc
Novartis
Inhibrx Biosciences, Inc
MacroGenics
DEKA Biosciences
Rapa Therapeutics LLC
Inhibrx Biosciences, Inc
iTeos Therapeutics
Presage Biosciences
Celldex Therapeutics
GeneMedicine Co., Ltd.
University Hospital, Ghent
Kineta Inc.
Seagen Inc.
Fate Therapeutics
Incyte Corporation
Incyte Corporation
Dynavax Technologies Corporation
Oncovir, Inc.
Lytix Biopharma AS